Northern Trust Corporation Common Stock vs uniQure N.V. Ordinary Shares — how do they compare? Northern Trust Corporation Common Stock trades at $162.48 (market cap $30.63B), while uniQure N.V. Ordinary Shares trades at $20.78 (market cap $1.48B). The key difference: Northern Trust Corporation Common Stock is far larger — about 20.7× uniQure N.V. Ordinary Shares's market cap, and Northern Trust Corporation Common Stock pays a 1.96% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Northern Trust Corporation Common Stock for 0 Days and uniQure N.V. Ordinary Shares for 0 Days on average.
| NTRS | QURE | |
|---|---|---|
Market Cap | $30.63B | $1.48B |
Volume | 964,550 | 2,488,780 |
Sector | Financials | Health |
52-Week High | $191.47 | $70.59 |
52-Week Low | $122.72 | $9.03 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | -$5.35B | $728.62M |
Dividend Yield | 1.96% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Northern Trust Corporation is a financial holding company that provides asset servicing, asset management, wealth management, and banking services through its Asset Servicing and Wealth Management segments. It serves corporations, institutions, and affluent individuals across US and international markets.
Read more on NTRS →uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →